A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-38518168 in Symptomatic Adult Subjects With Uncontrolled, Persistent Asthma
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Toreforant (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 30 Sep 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 02 Mar 2015 Planned primary completion date changed from 1 Jan 2015 to 1 Jul 2015, according to ClinicalTrials.gov record.
- 02 Mar 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.